These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Angioplasty for recurrent renal artery stenosis in flare-up of Hashimoto's thyroiditis. Lee ML; Wang YM Pediatr Int; 2015 Apr; 57(2):e23-6. PubMed ID: 25868954 [TBL] [Abstract][Full Text] [Related]
9. A Rare Case of Focal Renal Fibromuscular Dysplasia Treated With Angioplasty: A Case Report. Al-Falahi A; Al-Aghbari G; Al-Muriesh M Vasc Endovascular Surg; 2024 Feb; 58(2):209-212. PubMed ID: 37586716 [TBL] [Abstract][Full Text] [Related]
10. Midterm Outcomes of Angioplasty for Pediatric Renovascular Hypertension. Zhao L; Zhao X; Hu X; Yang H; Wu L J Vasc Interv Radiol; 2022 Apr; 33(4):399-407. PubMed ID: 34896573 [TBL] [Abstract][Full Text] [Related]
11. Long-term results of percutaneous transluminal angioplasty in renovascular hypertension. von Knorring J; Edgren J; Lepäntalo M Acta Radiol; 1996 Jan; 37(1):36-40. PubMed ID: 8611321 [TBL] [Abstract][Full Text] [Related]
12. Renovascular Hypertension with Progressive Atherosclerotic Renal Artery Stenosis in an Elderly Patient with Known Fibromuscular Dysplasia: A Case Report. Alex J; Rajpurohit D; Zughaib M Am J Case Rep; 2023 May; 24():e939881. PubMed ID: 37210595 [TBL] [Abstract][Full Text] [Related]
13. Presentation, treatment, and outcome of renovascular hypertension below 2 years of age. Kurt-Sukur ED; Brennan E; Davis M; Forman C; Hamilton G; Kessaris N; Marks SD; McLaren CA; Minhas K; Patel PA; Roebuck DJ; Stojanovic J; Stuart S; Tullus K Eur J Pediatr; 2022 Sep; 181(9):3367-3375. PubMed ID: 35792951 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous transluminal renal angioplasty (PTRA) as a method of therapy for renovascular hypertension in children. Simunić S; Winter-Fudurić I; Radanović B; Bradic I; Marinović B; Marinković M; Cavka K; Batinica S; Batinić D; Roglić M Eur J Radiol; 1990; 10(2):143-6. PubMed ID: 2140097 [TBL] [Abstract][Full Text] [Related]
15. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553 [TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and treatment of renal artery fibromuscular dysplasia with percutaneous transluminal angioplasty: a long-term follow-up study. Yang YK; Zhang Y; Meng X; Yang KQ; Jiang XJ; Wu HY; Zhang HM; Song L; Wang LP; Gao LG; Zhou XL Clin Res Cardiol; 2016 Nov; 105(11):930-937. PubMed ID: 27270759 [TBL] [Abstract][Full Text] [Related]
18. Percutaneous transluminal angioplasty with selective stenting for the treatment of renal artery stenosis caused by fibromuscular dysplasia: 18 years' experience from the China Center for Cardiovascular Disease. Chen Y; Dong H; Jiang X; Deng Y; Zou Y; Che W; Xiong H; Xu B; Yang Y; Gao R Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():641-647. PubMed ID: 31943685 [TBL] [Abstract][Full Text] [Related]